review the FDA's drug approval process, and more closely monitor its relationship with pharmaceutical companies.

The Food and Drug Administration should publicly disclose any financial and/or professional relationships with pharmaceutical companies.
Drugs pending approval should be tested and studied by an independent body that is not funded or influenced by pharmaceutical companies that would profit from it's approval.